Synlett 2015; 26(11): 1475-1479
DOI: 10.1055/s-0034-1380534
letter
© Georg Thieme Verlag Stuttgart · New York

Mechanistic Insights into Copper-Catalyzed Azide–Alkyne Cycloaddition (CuAAC): Observation of Asymmetric Amplification

Takao Osako
a   Institute for Molecular Science (IMS), Okazaki, Aichi 444-8787, Japan   Email: uo@ims.ac.jp
,
Yasuhiro Uozumi*
a   Institute for Molecular Science (IMS), Okazaki, Aichi 444-8787, Japan   Email: uo@ims.ac.jp
b   RIKEN Center for Sustainable Resource Science, Wako, Saitama 351-0198, Japan   Email: uo@riken.jp
› Author Affiliations
Further Information

Publication History

Received: 28 February 2015

Accepted after revision: 17 March 2015

Publication Date:
02 April 2015 (online)


Dedicated to Professor Peter Vollhardt for his peerless contribution to the broad discipline of organic chemistry

Abstract

A mechanistic study of copper-catalyzed azide–alkyne cy­cloaddition (CuAAC) was examined using an enantioposition-selective asymmetric CuAAC as a probe reaction system. Based on the observed asymmetric amplification (a positive nonlinear effect), we proposed that a dimeric chiral copper complex is involved as a reactive intermediate in the copper-catalyzed azide–alkyne cycloaddition.

 
  • References and Notes

  • 1 Kolb HC, Finn MG, Sharpless KB. Angew. Chem. Int. Ed. 2001; 40: 2004
    • 2a Organic Azides: Syntheses and Applications . Bräse S, Banert K. John Wiley and Sons; Chichester: 2010

    • For recent selected reviews on CuAAC, see:
    • 2b Bock VD, Hiemstra H, van Maarseveen JH. Eur. J. Org. Chem. 2006; 51
    • 2c Mose JE, Moorhouse AD. Chem. Soc. Rev. 2007; 36: 1249
    • 2d Wu P, Fokin VV. Aldrichimica Acta 2007; 40: 7
    • 2e Meldal M, Tornøe CW. Chem. Rev. 2008; 108: 2952
    • 2f Hein JE, Fokin VV. Chem. Soc. Rev. 2010; 39: 1302
    • 2g Agalave SG, Maujan SR, Pore VS. Chem. Asian J. 2011; 6: 2696
    • 2h Lallana E, Riguera R, Fernandez-Megia E. Angew. Chem. Int. Ed. 2011; 50: 8794
    • 3a Meng J.-c, Fokin VV, Finn MG. Tetrahedron Lett. 2005; 46: 4543
    • 3b Zhou F, Tan C, Tang J, Zhang Y.-Y, Gao W.-M, Wu H.-H, Yu Y.-H, Zhou J. J. Am. Chem. Soc. 2013; 135: 10994
    • 4a Hayashi T, Niizuma S, Kamikawa T, Suzuki N, Uozumi Y. J. Am. Chem. Soc. 1995; 117: 9101
    • 4b Kamikawa T, Uozumi Y, Hayashi T. Tetrahedron Lett. 1996; 37: 3161
    • 4c Zhou H, Uozumi Y. Synlett 2013; 24: 2550
    • 5a Osako T, Panichakul D, Uozumi Y. Org. Lett. 2012; 14: 194
    • 5b Yamada YM. A, Sarkar S, Uozumi Y. J. Am. Chem. Soc. 2012; 134: 9285
  • 6 Osako T, Uozumi Y. Org. Lett. 2014; 16: 5866

    • See reviews in ref. 2. For typical recent reports, see also:
    • 7a Himo F, Lovell T, Hilgraf R, Rostovtsev VV, Noodleman L, Sharpless KB, Fokin VV. J. Am. Chem. Soc. 2005; 127: 210
    • 7b Rodionov VO, Fokin VV, Finn MG. Angew. Chem. Int. Ed. 2005; 44: 2210
    • 7c Rodionov LO, Presolski SI, Díaz DD, Fokin VV, Finn MG. J. Am. Chem. Soc. 2007; 129: 12705
    • 7d Ahlquist M, Fokin VV. Organometallics 2007; 26: 4389
    • 7e Straub BF. Chem. Commun. 2007; 3868
    • 7f Hein JE, Tripp JC, Krasnova LB, Sharpless KB, Fokin VV. Angew. Chem. Int. Ed. 2009; 48: 8018
    • 7g Partyka DV, Gao L, Teets TS, Updegraff JB. III, Deligounul N, Gray TG. Organometallics 2009; 28: 6171
    • 7h Zhou Y, Lecourt T, Micouin L. Angew. Chem. Int. Ed. 2010; 49: 2607
    • 7i Presolski SI, Hong V, Cho S.-H, Finn MG. J. Am. Chem. Soc. 2010; 132: 14570
    • 7j Kuang G.-C, Guha PM, Brotherton WS, Simmons JT, Stankee LA, Nguyen BT, Clark RJ, Zhu L. J. Am. Chem. Soc. 2011; 133: 13984
    • 7k Worrell BT, Malik JA, Fokin VV. Science 2013; 340: 457
    • 8a Kagan HB, Fiaud JC. Topics in Stereochemistry . Vol. 18. Eliel EL, Fiaud JC. Wiley; New York: 1988: 249-330
    • 8b Kagan HB. Synlett 2001; 888
    • 8c Guillaneux D, Zhao S.-H, Samuel O, Rainford D, Kagan HB. J. Am. Chem. Soc. 1994; 116: 9430
    • 8d Johnson DW. Jr, Singleton DA. J. Am. Chem. Soc. 1999; 121: 9307
  • 9 The curve fittings were generated from eeproduct = 2ee0eeligand/(1 + eeligand 2) for the enantioposition-selective CuAAC or from DKEE = 2DKEE0eeligand/(1 + eeligand 2) for the kinetic resolution by the asymmetric CuAAC [K = 4, g = 0; statistical distribution conditions were applied for the formation of the potential reactive intermediates {chiral dimeric complexes (MLR)2, (MLs)2, and meso dimeric complex [(MLR)(MLs)]}.
  • 10 The reaction of 1a with 2 was examined with homochiral [CuI(L*)(triazole)]2(OTf)2 (metal/ligand = 1:1), which was prepared, isolated, and fully characterized (unpublished) to give (R)-3a in 65% yield and 82% ee, along with a 24% yield of bistriazole 4a, being in good agreement with the results shown in Table 1. This observation demonstrated that the catalytically active species should be a 1:1 Cu–L* complex. Thus, we excluded the possibility that a positive NLE is induced via the formation of an inactive 1:2 metal–ligand heterochiral complex, cf.: Saaby S, Nakama K, Lie MA, Hazell RG, Jørgensen KA. Chem. Eur. J. 2003; 9: 6145
  • 11 Procedure for the Copper-Catalyzed Cycloaddition In a glove box, CuOTf·(C6H6)0.5 (3.1 mg, 0.0125 mmol Cu) was charged into a screw vial. A solution of L* (12.6 mg, 0.025 mmol) in 1,2-DCE (250 μL) was added, and the mixture was stirred for 30 min. After addition of a solution of dialkyne 1a (0.125 mmol) in 1,2-DCE (250 μL) to the mixture, the reaction vial was taken from the glove box. After addition of benzyl azide (2, 24 μL, 0.188 mmol), the mixture was stirred at r.t. for 3 h. The resulting mixture was purified by flash SiO2 column to give the products 3a and 4a. Compound 3a: 1H NMR (396 MHz, CDCl3, 25 °C): δ = 8.39 (d, J = 7.5 Hz, 1 H, Ar), 7.80 (t, J = 7.5 Hz, 2 H, Ar), 7.67 (d, J = 7.5 Hz, 1 H, Ar), 7.52 (t, J = 7.9 Hz, Ar), 7.41 (t, J = 7.9 Hz, 2 H, Ar), 7.33–7.25 (m, 4 H, Ar), 7.19 (t, J = 7.5 Hz, 2 H, Ar), 6.68 (d, J = 7.1 Hz, 2 H, Ar), 5.61 (s, 1 H, triazole-H5), 5.08 (s, 2 H, PhCH2), 2.69 (s, 1 H, CH). 13C{1H} NMR (100 MHz, CDCl3, 25 °C): δ = 145.52, 140.31, 137.33, 133.97, 133.26, 132.60, 131.54, 131.14, 128.86, 128.47, 128.30, 128.23, 128.15, 128.12, 127.54, 127.31, 126.50, 126.00, 125.39, 125.24, 123.41, 121.88, 82.30, 80.49, 53.58. HRMS: m/z calcd for C27H19N3: 385.1579; found: 385.1576. IR (ATR, neat): 3286, 3261, 3057, 2959, 2936, 1945, 1878, 1721, 1606, 1593, 1574, 1547, 1496, 1453, 1438, 1391, 1370, 1348, 1296, 1261, 1247, 1229, 1214, 1156, 1121, 1094, 1074, 1050, 1026, 1007, 976, 962, 912, 893, 871, 846, 827, 798, 778, 756, 727, 691, 676, 661, 640, 628, 610, 589, 577, 566 cm–1. 91% ee from 1.5 equiv of 2 (HPLC conditions: Chiralpak IA column, MTBE, flow rate 1 mL min–1, wavelength = 255 nm, t R = 9.5 min for minor isomer, t R = 11.6 min for major isomer). [α]D 26 –82.5 (c 0.83, CHCl3). The absolute configuration of 3a was determined to be R based on the crystal structure of 3 bearing chloro group at the 4-position of the phenyl ring. For details, see ref. 6. Compound 4a: 1H NMR (396 MHz, CDCl3, 25 °C): δ = 8.32 (dd, J = 7.5, 1.2 Hz, 2 H, Ar), 7.73 (d, J = 8.3 Hz, 1 H, Ar), 7.68 (t, J = 7.9 Hz, 2 H, Ar), 7.39 (t, J = 7.9 Hz, 1 H, Ar), 7.33–7.13 (m, 4 H, Ar), 6.68 (d, J = 7.9 Hz, 4 H, Ar), 5.66 (s, 2 H, triazole-H5), 5.10 (s, 4 H, PhCH2). 13C{1H} NMR (100 MHz, CDCl3, 25 °C): δ = 146.10, 137.74, 135.07, 134.11, 133.11, 131.66, 131.14, 128.81, 128.75, 128.28, 128.24, 128.18, 127.65, 127.52, 126.92, 126.29, 125.48, 125.09, 121.72, 53.54. HRMS: m/z calcd for C34H26N6Na1: 541.2117; found: 541.2116. IR (ATR, neat): 3157, 3051, 2929, 2853, 2389, 2279, 1957, 1724, 1661, 1629, 1590, 1549, 1497, 1433, 1389, 1342, 1292, 1248, 1223, 1158, 1106, 1072, 1048, 921, 800, 779, 751, 704, 612, 588 cm–1.